Ford (F) To Launch F-150 Pickup Truck With V6 Diesel Engine

Ford Motor Company (NYSE:F) has announced that its plans to introduce a diesel engine enabled F-150 pickup truck through dealerships this spring onward. Last year, the company sold 896,764 F-series trucks compared with 820,000 in 2016.

The F-150 model with 3-liter Ford power stroke V6 diesel engine will be powered by 10-speed transmission in order to attain 30 miles per gallon of highway fuel efficiency. Additionally, the model will have 11,400 pounds of towing capacity and 2,020 pounds of payload capacity.

The diesel version of F-150 is expected at a price between $2,400 and $4,000, higher than a similar gasoline truck.

Ford Motor Company Price and Consensus

Ford Motor Company Price and Consensus | Ford Motor Company Quote

Sale of pickup trucks has surged of late in the United States on a strong fuel economy.

Aimed at customers, towing large recreational or work trailers, the company’s F-150 diesel model is in line with other automakers, who are ramping up their pickup product line to gain from the rise in truck demand.

Ford’s dealers will start taking orders for the 2018 F-150 version equipped with 3.0-liter power stroke diesel engine from mid-January.

Price Performance

In the last three months, shares of Ford have gained 7%, outperforming the 0.5% decline for the industry it belongs to.

Zacks Rank & Key Picks

Ford carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the auto space are Volkswagen (DE:VOWG_p) AG (OTC:VLKAY) , Lear Corporation (NYSE:LEA) and LKQ Corporation (NASDAQ:LKQ) , all carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Volkswagen has an expected long-term growth rate of 12.9%. In the last three months, shares of the company have rallied 24.7%.

Lear has an expected long-term growth rate of 7.1%. In the last three months, shares of the company have climbed 10.1%.

LKQ Corp. has an expected long-term growth rate of 16%. In the last three months, shares of the company have jumped 14.7%.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>